SCHEMBL19706901

SCHEMBL19706901

CCOC(=O)C1(NC(=O)OC(C)(C)C)CCC(=O)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.40
CYP2C19 P33261 5/20 0.35
CYP3A4 P08684 2/20 0.35
ALDH1A1 P00352 3/20 0.34
KMT2A Q03164 3/20 0.34
TSHR P16473 2/20 0.34
MEN1 O00255 2/20 0.34
CYP2C9 P11712 2/20 0.33
CYP1A2 P05177 1/20 0.33
HTT P42858 1/20 0.33
POLB P06746 1/20 0.33
NFKB1 P19838 3/20 0.33
NFKB2 Q00653 3/20 0.33
RELA Q04206 3/20 0.33
APLNR P35414 1/20 0.33
TLR2 O60603 1/20 0.33
TLR1 Q15399 1/20 0.33
ATM Q13315 1/20 0.32
CYP2D6 P10635 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL583634 0.88 KMT2A (0.38) GHSRCYP2C19ALDH1A1KMT2ATSHR
SCHEMBL18482458 0.87 GHSR (0.38) GHSRALDH1A1KMT2ATSHRAPLNR
SCHEMBL16112133 0.86 GHSR (0.37) GHSRCYP2C19ALDH1A1KMT2ATSHR
SCHEMBL1351011 0.85 LATS1 (0.37) GHSRCYP2C19CYP3A4ALDH1A1KMT2A
SCHEMBL2745084 0.85 GHSR (0.38) GHSRALDH1A1KMT2AMEN1NFKB1
SCHEMBL19388803 0.83 GHSR (0.42) GHSRALDH1A1KMT2AMEN1NFKB1
SCHEMBL2781817 0.82 OPRM1 (0.42) GHSRCYP2C19ALDH1A1KMT2ATSHR
SCHEMBL2746842 0.82 GHSR (0.36) GHSRCYP2C19ALDH1A1KMT2ATSHR
SCHEMBL18482457 0.81 SYK (0.45) GHSRKMT2ACTSL
SCHEMBL1953820 0.81 GHSR (0.39) GHSRALDH1A1KMT2AMEN1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640488-B2 Antibacterial compounds AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2020-05-05 US disclosed
US-10640488-B2 Antibacterial compounds AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2020-05-05 US disclosed
US-10633366-B2 Antibacterial compounds AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2020-04-28 US disclosed
US-10633366-B2 Antibacterial compounds AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2020-04-28 US disclosed
EP-3468975-B1 NEW ANTIBACTERIAL COMPOUNDS ACRAF (IT) 2020-04-01 EP disclosed
US-20200095225-A9 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2020-03-26 US disclosed
US-20200095225-A9 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2020-03-26 US disclosed
US-20190256495-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2019-08-22 US disclosed
US-20190256495-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2019-08-22 US disclosed
US-20190161472-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2019-05-30 US disclosed
US-20190161472-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2019-05-30 US disclosed
WO-2017211760-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2017-12-14 WO disclosed
WO-2017211759-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2017-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190161472-A1 NEW ANTIBACTERIAL COMPOUNDS MRPL21, LAS1L, MRPL19 GHSR 1825/4885CYP2C19 1329/4885CYP3A4 2112/4885
US-20200095225-A9 NEW ANTIBACTERIAL COMPOUNDS MRPL21, CLPP, NRDC GHSR 4630/4885CYP2C19 3470/4885CYP3A4 3159/4885
US-10633366-B2 Antibacterial compounds MRPL21, LAS1L, MRPL19 GHSR 1520/4885CYP2C19 857/4885CYP3A4 1529/4885
US-20190256495-A1 NEW ANTIBACTERIAL COMPOUNDS MRPL21, CLPP, NRDC GHSR 4630/4885CYP2C19 3470/4885CYP3A4 3159/4885
US-10640488-B2 Antibacterial compounds MRPL21, CLPP, NRDC GHSR 4627/4885CYP2C19 2916/4885CYP3A4 2153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.